Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 5, 2010, Pages 496-499

  Rosenvinge, Melanie M ^a   Gedela, Keertie ^a   Copas, Andrew J ^b   Wilkinson, Anne ^b   Sheehy, Catriona A ^a   Bano, Gul ^a   Hay, Phillip E ^c   Pakianathan, Mark R ^a   Sadiq, S Tariq ^c  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

creatinine; hyperparathyroidism; tenofovir; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; TENOFOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM; VITAMIN D DEFICIENCY;

ADENINE; ADULT; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHONIC ACIDS; URBAN POPULATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77954762865     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181caebaa     Document Type: Article

References (10)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
2. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24: 1375-1382.
3. Childs K, Fishman S, Bateman K, et al. Should vitamin D be prescribed with tenofovir/FTC? Presented at: 48th International Conference on Antimicrobial Agents and Chemotherapy; October 25-28, 2008; Washington, DC.
4. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860-868.
5. Stephenson CB, Marquis GS, Kruzich LA, et al. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr. 2006; 83:1135-1141.
6. Labarga P, Barreiro P, Martin-Carbonero L, et al. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009;23:689-696.
7. Gallant JE, Parish MA, Keruly JC, et al. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis. 2005; 40:1194-1198. Epub March 17, 2005.
8. Tai K, Need AG, Horowitz M, et al. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition. 2008;24:279-285.
9. Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1a,25-dihyroxyvitamin D3: implications for drug-induced osteomalacia. Mol Pharmacol. 2006;69:56-65.
10. Faucette SR, Zhang TC, Moore R, et al. Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther. 2007;320:72-80.